Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sysco | SYY | Sep 27, 2024 | 77.66 | -0.38 |
System1 A | SST | Sep 27, 2024 | 1.11 | +1.83 |
T Stamp A | IDAI | Sep 27, 2024 | 0.22 | +5.02 |
T-Mobile US | TMUS | Sep 27, 2024 | 205.18 | +0.95 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Sep 27, 2024 | 39.46 | -0.68 |
T. Rowe Price Dividend Growth ETF | TDVG | Sep 27, 2024 | 40.78 | +0.02 |
T. Rowe Price Equity Income ETF | TEQI | Sep 27, 2024 | 41.72 | +0.62 |
T. Rowe Price Group | TROW | Sep 27, 2024 | 109.51 | +0.12 |
T. Rowe Price Growth Stock ETF | TGRW | Sep 27, 2024 | 37.48 | -0.53 |
T2 Biosystems | TTOO | Sep 27, 2024 | 2.00 | +1.01 |
Taboola.com | TBLA | Sep 27, 2024 | 3.28 | +0.31 |
Tactile Systems Technology | TCMD | Sep 27, 2024 | 14.22 | -0.91 |
Taitron Components A | TAIT | Sep 27, 2024 | 2.91 | +0.69 |
Taiwan Fund | TWN | Sep 27, 2024 | 45.01 | -0.79 |
Taiwan Index MSCI Ishares | EWT | Sep 27, 2024 | 55.50 | -1.56 |
Taiwan Semiconductor Manufacturing ADR | TSM | Sep 27, 2024 | 177.97 | -4.74 |
Take-Two Interactive Software | TTWO | Sep 27, 2024 | 153.05 | +0.90 |
Takeda Pharmaceutical ADR | TAK | Sep 27, 2024 | 14.54 | -0.75 |
TAL Education Group ADR | TAL | Sep 27, 2024 | 10.80 | +5.06 |
Talen Energy | TLN | Sep 27, 2024 | 182.22 | 0.00 |
Talis Biomedical | TLIS | Sep 27, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Sep 27, 2024 | 2.03 | +2.01 |
Talos Energy | TALO | Sep 27, 2024 | 10.19 | +1.39 |
Talphera | TLPH | Sep 27, 2024 | 0.86 | +6.10 |
Tamboran Resources | TBN | Sep 27, 2024 | 20.00 | 0.00 |
Tandem Diabetes Care | TNDM | Sep 27, 2024 | 42.45 | -3.70 |
Tanger | SKT | Sep 27, 2024 | 33.00 | +1.38 |
Tango Therapeutics | TNGX | Sep 27, 2024 | 7.47 | +1.49 |
Tantech | TANH | Sep 27, 2024 | 0.18 | +4.83 |
Taoping | TAOP | Sep 27, 2024 | 0.78 | +18.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.